Automated Apnoea Detection in Preterms on Non-invasive Ventilation
Prospective Observational Study of Automated Apnoea Detection in Preterm Infants Receiving Non-invasive Respiratory Support
The aim of this study is to monitor the frequency of apnoeas (pauses in breathing) on various methods of non-invasive respiratory support that are detected by an automated machine-learning (ML) model based on diaphragmatic electromyography (dEMG), in infants born at less than 32 weeks of gestation.
Our hypothesis is that the ML algorithm will improve identification of apnoeic episodes and their classification to central or obstructive.
The study will measure outcomes including the number of apnoeic episodes during the monitoring period, their classification to central and obstructive apnoeas and the predictive ability of the machine-learning algorithm to correctly identify and classify these episodes compared to those documented in nursing charts. Correct classification of apnoeic episodes may help identify underlying causes that require specific intervention.
연구 개요
상세 설명
When the clinical team identifies an infant is eligible for enrolment to the study and following verbal assent of the attending neonatal consultant, a member of clinical staff will initially approach the parents/ legal guardians of eligible infants and if they agree, a researcher. The parents will be provided with an information sheet about the study. The researchers will answer questions and respond to any concerns in a face-to-face meeting. Written informed consent will be obtained.
Electrical activity of the diaphragm, airway pressure, flow and peripheral oxygen saturation levels will be recorded for a duration of eight hours. Transcutaneous diaphragm EMG (sEMG) will be monitored using three surface electrodes (3M Red Dot Foam monitoring electrode 2228, 3M, United Kingdom) that are placed on the infant's abdomen and sternum. The electrodes are connected to a small battery-operated measuring device (SERA, DEMCON; Makawi Medical Systems, the Netherlands) that amplifies and pre-processes the signals received from the electrodes. The pre-processed signals are sent via a Bluetooth connection to a receiving unit that performs higher level processing to derive the EMG signal and other measurements. These results are communicated via a wired connection to a bedside computer running SERA Graphical User Interface (GUI) software.
Airway pressure and flow signals will be measured by a flow sensor and pressure tube (Sensirion AG, Stäfa, Switzerland) that will be placed between the exit of the SLE6000/ SLE6000N ventilators (Inspiration Healthcare, Croydon, UK) and the tubing that is attached to the patient. This will ensure pressure and flow data are recorded simultaneously with the sEMG signal. These data will also be fed to the SERA measuring device.
An SpO2 cable (SLE uSpO2, Inspiration Healthcare, Croydon, UK) will be connected to the patient and the ventilator for continuous (second by second) recording of SpO2 levels. These data will be time synced using post processing.
Participants will also be connected to the standard bedside monitor (Phillips Intellivue MX750) for the whole duration of the study.
Surface EMG, pressure, flow and SpO2 data will be synchronised. Two researchers will identify all apnoeic episodes and classify them as central, obstructive or noise.
The ML algorithm will also be used to identify and classify apnoeic episodes that occurred during the study duration.
Comparisons will be made between the apnoeic episodes identified the researchers, the ML algorithm and the nursing staff electronic patient records. These records include classification of an episode as apnoea or desaturation or bradycardia, its duration and any actions taken.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Ourania Kaltsogianni, MD (Res)
- 전화번호: 38494 0044+02032999000
- 이메일: ourania.kaltsogianni@nhs.net
참여기준
자격 기준
공부할 수 있는 나이
- 어린이
건강한 자원 봉사자를 받아들입니다
샘플링 방법
연구 인구
설명
Inclusion Criteria:
Preterm infants <32 weeks of gestation at birth and up to 36 weeks postmenstrual age, on non-invasive respiratory support including:
- non-invasive positive pressure ventilation (NIPPV)
- nasal continuous positive airway pressure (CPAP)
- heated humidified high flow nasal cannula (HHFNC) oxygen, either as primary or post extubation respiratory support.
Exclusion Criteria:
- Infants born above 32 weeks of gestation.
- Infants with known major congenital abnormalities.
- Infants above 36 weeks postmenstrual age (PMA).
- Non-English speakers.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
Number of apnoeic episodes correctly identified by the automated machine learning model
기간: From enrollment to the end of monitoring at eight hours
|
From enrollment to the end of monitoring at eight hours
|
2차 결과 측정
결과 측정 |
기간 |
|---|---|
|
The proportion of apnoeas correctly classified as central or obstructive by the automated machine learning model
기간: From enrollment to the end of monitoring at eight hours
|
From enrollment to the end of monitoring at eight hours
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Anne Greenough, Professor, King's College Hospital NHS Trust
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 371040
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .